Objective: To determine factors associated with outcomes following pelvic exenteration for advanced nonrectal pelvic malignancy. Background: The PelvEx Collaborative provides large volume data from specialist centers to ascertain factors associated with improved outcomes. Methods: Consecutive patients who underwent pelvic exenteration for nonrectal pelvic malignancy between 2006 and 2017 were identified from 22 tertiary centers. Patient demographics, neoadjuvant therapy, histopathological assessment, length of stay, 30-day major complication/mortality rate were recorded.The primary endpoints were factors associated with survival. The secondary endpoints included the difference in margin rates across the cohorts, impact of neoadjuvant ...
Introduction: Complete resection is the most important prognostic factor in surgery for pelvic tumor...
OBJECTIVE The aim of this study was to analyze the clinical experience and outcome of patients who h...
OBJECTIVE: Evaluate the survival of patients who underwent pelvic exenteration (PE) with curative in...
Objective: To determine factors associated with outcomes following pelvic exenteration for advanced ...
Objective: To determine factors associated with outcomes following pelvic exenteration for advanced ...
Background: Pelvic exenteration for locally recurrent rectal cancer (LRRC) is associated with variab...
Objective: To analyze the clinical outcome of patients after pelvic exenteration for advanced primar...
Objective: The aim of the study was to analyze data from an international collaboration, and ascerta...
Objective: Evaluation of surgical outcomes, survival, and morbidity associated with pelvic exenterat...
OBJECTIVE: Our study purpose was to evaluate morbidity and postoperative mortality in patients who ...
Objective: Our study purposewas to evaluatemorbidity and postoperative mortality in patients who und...
OBJECTIVE: The aim of this study was to summarize the clinical experience at our clinic with pelvic ...
Background: In patients with locally advanced or recurrent pelvic malignancies, total pelvic exenter...
Of 153 patients with primary or recurrent pelvic malignancy referred for consideration of exenterati...
Introduction: Complete resection is the most important prognostic factor in surgery for pelvic tumor...
OBJECTIVE The aim of this study was to analyze the clinical experience and outcome of patients who h...
OBJECTIVE: Evaluate the survival of patients who underwent pelvic exenteration (PE) with curative in...
Objective: To determine factors associated with outcomes following pelvic exenteration for advanced ...
Objective: To determine factors associated with outcomes following pelvic exenteration for advanced ...
Background: Pelvic exenteration for locally recurrent rectal cancer (LRRC) is associated with variab...
Objective: To analyze the clinical outcome of patients after pelvic exenteration for advanced primar...
Objective: The aim of the study was to analyze data from an international collaboration, and ascerta...
Objective: Evaluation of surgical outcomes, survival, and morbidity associated with pelvic exenterat...
OBJECTIVE: Our study purpose was to evaluate morbidity and postoperative mortality in patients who ...
Objective: Our study purposewas to evaluatemorbidity and postoperative mortality in patients who und...
OBJECTIVE: The aim of this study was to summarize the clinical experience at our clinic with pelvic ...
Background: In patients with locally advanced or recurrent pelvic malignancies, total pelvic exenter...
Of 153 patients with primary or recurrent pelvic malignancy referred for consideration of exenterati...
Introduction: Complete resection is the most important prognostic factor in surgery for pelvic tumor...
OBJECTIVE The aim of this study was to analyze the clinical experience and outcome of patients who h...
OBJECTIVE: Evaluate the survival of patients who underwent pelvic exenteration (PE) with curative in...